J07BK02 • zoster vaccine • Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines
The shingles vaccine is used to prevent shingles, a condition caused by the reactivation of the varicella-zoster virus (VZV) in individuals who have had chickenpox. Shingles is characterized by a painful rash and can lead to severe complications such as postherpetic neuralgia. The shingles vaccine stimulates the immune system to recognize and combat the virus, reducing the risk of disease occurrence and symptom severity.
There are two types of shingles vaccines: the live attenuated vaccine and the recombinant vaccine. The live attenuated vaccine is administered subcutaneously, while the recombinant vaccine is administered intramuscularly. Both are especially recommended for individuals over the age of 50.
Common side effects include pain at the injection site, fatigue, mild fever, and muscle aches. In rare cases, severe allergic reactions may occur.
The shingles vaccine is an important preventive measure for older adults, helping to reduce the incidence and impact of shingles on quality of life.
Substance: zoster vaccine
Date of last drug list: 01-07-2013
Commercial code: W51782011
Pharmaceutical form: powder + solvent for injection suspension in pre-filled syringe
Quantity: 20
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).